Klaus Kølendorf

Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsbøll, Birgitte Brock, Hans Perrild et al. · Diabetic Medicine · 2008 · 213 citations

Medicine, Endocrinology, Pharmacology +17

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes

Kjeld Hermansen, Michele Colombo, Heidi Storgaard et al. · Diabetes Care · 2002 · 130 citations

Medicine, Endocrinology, Pharmacotherapy +15

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

Klaus Kølendorf, Glynis P. Ross, G. Perriello et al. · Diabetic Medicine · 2006 · 109 citations

Medicine, Endocrinology, Pharmacotherapy +15

Clinical Factors Influencing the Absorption of¹²⁵I-NPH Insulin in Diabetic Patients

Klaus Kølendorf, J. Bojsen, T. Deckert · Hormone and Metabolic Research · 1983 · 74 citations

Pharmacy, Endocrinology, Pharmacokinetics +14